Zoetis, Inc. (ZTS)
79.38
+0.96
(+1.22%)
USD |
NYSE |
Oct 16, 16:00
79.53
+0.15
(+0.19%)
After-Hours: 20:00
Zoetis Cash from Investing (Quarterly) : -300.00M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -300.00M |
| March 31, 2026 | -87.00M |
| December 31, 2025 | -166.00M |
| September 30, 2025 | -160.00M |
| June 30, 2025 | -212.00M |
| March 31, 2025 | -203.00M |
| December 31, 2024 | 126.00M |
| September 30, 2024 | -178.00M |
| June 30, 2024 | -132.00M |
| March 31, 2024 | -131.00M |
| December 31, 2023 | -210.00M |
| September 30, 2023 | -271.00M |
| June 30, 2023 | -80.00M |
| March 31, 2023 | -216.00M |
| December 31, 2022 | -438.00M |
| September 30, 2022 | -124.00M |
| June 30, 2022 | -203.00M |
| March 31, 2022 | -118.00M |
| December 31, 2021 | -142.00M |
| September 30, 2021 | -114.00M |
| June 30, 2021 | -139.00M |
| March 31, 2021 | -63.00M |
| December 31, 2020 | -177.00M |
| September 30, 2020 | -174.00M |
| June 30, 2020 | -161.00M |
| Date | Value |
|---|---|
| March 31, 2020 | -57.00M |
| December 31, 2019 | -213.00M |
| September 30, 2019 | -209.00M |
| June 30, 2019 | -59.00M |
| March 31, 2019 | -23.00M |
| December 31, 2018 | -74.00M |
| September 30, 2018 | -2.09B |
| June 30, 2018 | -76.00M |
| March 31, 2018 | -45.00M |
| December 31, 2017 | -97.00M |
| September 30, 2017 | -128.00M |
| June 30, 2017 | -40.00M |
| March 31, 2017 | -48.00M |
| December 31, 2016 | -59.00M |
| September 30, 2016 | -124.00M |
| June 30, 2016 | -49.00M |
| March 31, 2016 | 18.00M |
| December 31, 2015 | -737.00M |
| September 30, 2015 | -60.00M |
| June 30, 2015 | -44.00M |
| March 31, 2015 | -274.00M |
| December 31, 2014 | -50.00M |
| September 30, 2014 | -42.00M |
| June 30, 2014 | -50.00M |
| March 31, 2014 | -45.00M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly & Co. | -15.40B |
| Merck & Co., Inc. | -5.602B |
| Pfizer Inc. | 2.106B |
| Phibro Animal Health Corp. | -16.45M |
| Bristol Myers Squibb Co. | -1.614B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 655.00M |
| Cash from Financing (Quarterly) | -813.00M |
| Free Cash Flow | 2.366B |
| Free Cash Flow Per Share (Quarterly) | 1.288 |
| Free Cash Flow to Equity (Quarterly) | 538.00M |
| Free Cash Flow to Firm (Quarterly) | 591.46M |
| Free Cash Flow Yield | 6.92% |